Catch me if you can: how AML and its niche escape immunotherapy.
Catch me if you can: how AML and its niche escape immunotherapy.
复制标题
DOI:
10.1038/s41375-021-01350-x
复制
发表时间:
2022-01
期刊:
影响因子:
11.4
通讯作者:
Serafini M
中科院分区:
文献类型:
--
作者:
Tettamanti S;Pievani A;Biondi A;Dotti G;Serafini M
In spite of the remarkable progress in basic and preclinical studies of acute myeloid leukemia (AML), the five-year survival rate of AML patients remains poor, highlighting the urgent need for novel and synergistic therapies. Over the past decade, increased attention has been focused on identifying suitable immunotherapeutic strategies for AML, and in particular on targeting leukemic cells and their progenitors. However, recent studies have also underlined the important contribution of the leukemic microenvironment in facilitating tumor escape mechanisms leading to disease recurrence. Here, we describe the immunological features of the AML niche, with particular attention to the crosstalk between the AML blasts and the cellular components of the altered tumor microenvironment (TME) and the mechanisms of immune escape that hamper the therapeutic effects of the most advanced treatments. Considering the AML complexity, immunotherapy approaches may benefit from a rational combination of complementary strategies aimed at preventing escape mechanisms without increasing toxicity.
登录
查看更多内容
影响因子:
64.5
作者:
Baryawno, Ninib;Przybylski, Dariusz;Scadden, David T.
通讯作者:
Scadden, David T.
影响因子:
3.9
作者:
Ager A;Watson HA;Wehenkel SC;Mohammed RN
通讯作者:
Mohammed RN
DOI:
10.1073/pnas.2020459118
发表时间:
2021-06-01
影响因子:
11.1
作者:
Chretien AS;Devillier R;Granjeaud S;Cordier C;Demerle C;Salem N;Wlosik J;Orlanducci F;Gorvel L;Fattori S;Hospital MA;Pakradouni J;Gregori E;Paul M;Rochigneux P;Pagliardini T;Morey M;Fauriat C;Dulphy N;Toubert A;Luche H;Malissen M;Blaise D;Nunès JA;Vey N;Olive D
通讯作者:
Olive D
影响因子:
20.3
作者:
Aurelius, Johan;Thoren, Fredrik B.;Martner, Anna
通讯作者:
Martner, Anna
影响因子:
7.5
作者:
Bruck, Oscar;Dufva, Olli;Mustjoki, Satu
通讯作者:
Mustjoki, Satu